Symetis pulls heart valves IPO for "market conditions"
Symetis, the Swiss heart valves maker, cancelled its planned initial public offering in Zurich on Tuesday, blaming “adverse market conditions” for the decision.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts